Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 06, 2022 17:30 ET | Source: Elevar Therapeutics

Elevar Therapeutics Shares Results of Phase 2 Rivoceranib Trial in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma

CHICAGO, June 06, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who have...
June 02, 2022 14:26 ET | Source: Elevar Therapeutics

Elevar Therapeutics Adds Drs. Honghui Zhou and David Lilienfeld as Vice Presidents

Biopharmaceutical company promotes Jennifer Lee to senior vice president of clinical operations, data management and biostatistics SALT LAKE CITY, June 02, 2022 (GLOBE NEWSWIRE) -- Elevar...
May 26, 2022 17:00 ET | Source: Elevar Therapeutics

Elevar Therapeutics Announces Rivoceranib Demonstrated Clinical Effectiveness in Patients with Progressive Recurrent or Metastatic Adenoid Cystic Carcinoma in a Phase 2 Trial

Results of open-label, multicenter study will be presented during a poster session at ASCO on June 6 Rivoceranib represents a potential new treatment option for patients with R/M ACC who have...
May 23, 2022 10:15 ET | Source: Elevar Therapeutics

Elevar Therapeutics Names Paul Friel Chief Commercial Officer, Michael Palucki VP of Manufacturing

SALT LAKE CITY, May 23, 2022 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a fully integrated biopharmaceutical company dedicated to elevating treatment experiences and outcomes for patients who...